Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Calcium ion (Ca2+) dysregulation is implicated in tumor progression, affecting proliferation, migration, and drug resistance.
• Calcium channels are crucial for maintaining cellular Ca2+ homeostasis and are often overexpressed in cancer cells.
• These channels represent viable targets for novel anticancer therapeutic strategies.

Purpose of the Study:

• To review the current understanding of calcium ion channels in cancer.
• To explore how these channels influence key tumor functions like epithelial-mesenchymal transition (EMT), metabolism, and drug resistance.
• To summarize recent advancements in small-molecule drugs targeting calcium channels for cancer treatment.

Main Methods:

• Literature review of current research on calcium channels in cancer.
• Analysis of studies investigating the role of calcium channels in tumor proliferation, migration, EMT, metabolism, and drug resistance.
• Survey of recent (5-year) developments in small-molecule drugs targeting calcium channels.

Main Results:

• Calcium ion dysregulation significantly affects tumor cell behavior.
• Calcium channels modulate critical cancer processes including EMT, metabolic reprogramming, and acquired drug resistance.
• Emerging small-molecule drugs targeting these channels show potential for antitumor applications.

Conclusions:

• Calcium channels are key regulators of cancer cell physiology and represent promising therapeutic targets.
• Targeting calcium ion homeostasis offers a viable strategy for developing novel anticancer drugs.
• Recent progress in small-molecule drug development highlights the therapeutic potential of targeting calcium channels in oncology.